International Biotechnology Trust’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

International Biotechnology Trust’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-12,000	Closed	-$369K	–	65
2018 Q4	$369K	Hold	12,000	–	–	0.23%	44
2018 Q3	$502K	Hold	12,000	–	–	0.24%	49
2018 Q2	$992K	Hold	12,000	–	–	0.38%	47
2018 Q1	$799K	Hold	12,000	–	–	0.31%	58
2017 Q4	$617K	Hold	12,000	–	–	0.22%	61
2017 Q3	$1.07M	Buy	+12,000	New	+$911K	0.42%	44

Other funds holding ONCE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

International Biotechnology Trust's ONCE Position: Q1 2019 in Review

International Biotechnology Trust sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q1 2019, closing a stake of 12,000 shares — an estimated $369K sold.

International Biotechnology Trust first reported a position in ONCE in Q3 2017 and held it in 6 quarters. The position peaked at $1.07M in Q3 2017. 199 funds tracked by Wall St. Rank hold ONCE as of Q1 2019.

International Biotechnology Trust reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
International Biotechnology Trust sold 12,000 Spark Therapeutics, Inc. Common Stock shares in Q1 2019, an estimated $369K.
International Biotechnology Trust first reported a position in Spark Therapeutics, Inc. Common Stock in Q3 2017 and held it in 6 quarters.
International Biotechnology Trust's Spark Therapeutics, Inc. Common Stock position peaked at $1.07M in Q3 2017.
199 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q1 2019.

Based on International Biotechnology Trust's 13F filing for Q1 2019, filed 14 May 2019.